These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498 [TBL] [Abstract][Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
5. Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway. Sun CC; Li SJ; Yang CL; Xue RL; Xi YY; Wang L; Zhao QL; Li DJ J Biol Chem; 2015 Jul; 290(29):17784-17795. PubMed ID: 26013831 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy. Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792 [TBL] [Abstract][Full Text] [Related]
7. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice. Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436 [TBL] [Abstract][Full Text] [Related]
8. Deletion of Dux ameliorates muscular dystrophy in mdx mice by attenuating oxidative stress via Nrf2. Sun S; Zhai W; Zhang R; Cai N FASEB J; 2024 Jul; 38(14):e23771. PubMed ID: 38989564 [TBL] [Abstract][Full Text] [Related]
10. Disruption of nuclear factor (erythroid-derived-2)-like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscle. Shelar SB; Narasimhan M; Shanmugam G; Litovsky SH; Gounder SS; Karan G; Arulvasu C; Kensler TW; Hoidal JR; Darley-Usmar VM; Rajasekaran NS FASEB J; 2016 May; 30(5):1865-79. PubMed ID: 26839378 [TBL] [Abstract][Full Text] [Related]
11. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment. Anderson JE; Vargas C Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794 [TBL] [Abstract][Full Text] [Related]
12. Cathelicidin-related antimicrobial peptide mediates skeletal muscle degeneration caused by injury and Duchenne muscular dystrophy in mice. Choi MC; Jo J; Lee M; Park J; Yao TP; Park Y J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3091-3105. PubMed ID: 36059045 [TBL] [Abstract][Full Text] [Related]
13. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy. Mojumdar K; Giordano C; Lemaire C; Liang F; Divangahi M; Qureshi ST; Petrof BJ J Pathol; 2016 May; 239(1):10-22. PubMed ID: 26800321 [TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy. Gutpell KM; Hrinivich WT; Hoffman LM PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927 [TBL] [Abstract][Full Text] [Related]
15. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points. Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817 [TBL] [Abstract][Full Text] [Related]
16. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy. Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083 [TBL] [Abstract][Full Text] [Related]
17. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model. Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144 [TBL] [Abstract][Full Text] [Related]
18. Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in Swiderski K; Read SJ; Chan AS; Chung JD; Trieu J; Naim T; Koopman R; Lynch GS Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960110 [TBL] [Abstract][Full Text] [Related]